TOPLINE: Compared with DPP-4 inhibitor therapy, sustained GLP-1 receptor agonist (GLP-1 RA) therapy was associated with greater short and longterm improvements in A1c levels and a modest reduction in the risk for all-cause mortality in patients with type 2 diabetes (T2D)
Splitting doses throughout the day may enhance results
Glutathione supports liver function, boosts immune response, and improves energy levels, making it indispensable for overall health and wellness
El HageRKhalafYAbou FayssalSHammoudMEl SebaalyZSassineYN
Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study
The FLOW trial, a double-blind, placebo-controlled study examining renal outcomes in patients with type 2 diabetes and chronic kidney disease, demonstrated that semaglutide reduced the progression of kidney disease by 24% compared to placebo